Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Craniopharyngiomas are tumors of the central nervous system, typically located in the sellar/parasellar region. Despite being benign, they behave aggressively due to their propensity to invade nearby important structures, making total resection challenging. Distant spread of craniopharyngioma is a rare but significant complication. Most cases result from spread along the surgical path, while others result from dissemination along the cerebrospinal fluid (CSF) pathways. We report a case of a parasellar adamantinomatous craniopharyngioma with progressive visual loss. The patient was operated on through a right pterional craniotomy three times due to recurrence. After the last surgery, fractionated stereotactic radiotherapy was performed on the tumor residue. On follow-up brain MRI, a new extra-axial lesion was found in the left frontal region with solid and cystic components, with apparent dural implantation. Left frontal craniotomy was performed, and the lesion was excised with resection of its dural implant. Histological findings revealed it to be adamantinomatous craniopharyngioma, grade 1, according to the World Health Organization (WHO). Despite being rare, craniopharyngioma ectopic recurrence is a possible surgical complication. Despite the poorly understood mechanism, the literature highlights the importance of paying attention to tumor spillage during surgery to prevent distant recurrences.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11486633PMC
http://dx.doi.org/10.7759/cureus.69607DOI Listing

Publication Analysis

Top Keywords

adamantinomatous craniopharyngioma
8
left frontal
8
ectopic craniopharyngioma
4
craniopharyngioma recurrence
4
recurrence case
4
case report
4
report literature
4
literature review
4
review craniopharyngiomas
4
craniopharyngiomas tumors
4

Similar Publications

Adamantinomatous craniopharyngiomas (ACPs) are rare, sellar-suprasellar benign tumors that cause considerable morbidity and mortality due to local invasion and treatment-related damage to surrounding structures, including central diabetes insipidus (CDI). Trametinib is a highly selective inhibitor of MEK1 and MEK2, which has been evaluated in both adult and pediatric cancers/ tumors with activation of the oncogenic mitogen-activated protein kinase (MAPK) pathway. Despite being thought to have fewer side effects than conventional cytotoxic chemotherapy, off-target toxicities such as hyponatremia have been described.

View Article and Find Full Text PDF

Objectives: The two histologic subtypes of craniopharyngiomas (CPs), papillary and adamantinomatous, harbor mutually exclusive mutations of BRAF V600E and CTNNB1, respectively. Studies suggest that subtotal resection (STR) plus adjuvant radiation therapy (XRT) may result in similar progression-free survival (PFS) as gross total resection (GTR). We hypothesized that STR ± XRT and GTR result in similar PFS for both BRAF and β-catenin-mutated CPs.

View Article and Find Full Text PDF

Objective: To evaluate the efficacy and safety of targeted molecular therapy for recurrent and refractory papillary craniopharyngioma (PCP) and explore its potential as a neoadjuvant treatment.

Methods: This systematic and narrative review was performed following PRISMA guidelines to evaluate BRAF and MEK inhibitors in treating PCP. PubMed, EMBASE, and Web of Science were searched up to July 2025.

View Article and Find Full Text PDF

Craniopharyngiomas are the most common non-neuroepithelial intracerebral neoplasms in children but rarely occur before birth, and are typically associated with a poor prognosis. We present the case of a 39-year-old woman with a spontaneously conceived singleton pregnancy. At 20 weeks of gestation, ultrasound detected a 44×25 mm heterogeneously hyperechogenic intracranial mass located at the base of the sphenoid bone, extending bilaterally.

View Article and Find Full Text PDF

Objective: This study aims to investigate the alterations in structural and functional connectivity networks (SCN and FCN) in children with hypothalamic syndrome (HS) following craniopharyngioma resection and to explore the relationship between these network changes and clinical manifestations.

Materials And Methods: We performed graph theory analysis on SCN and FCN derived from 36 patients with HS and 36 age- and sex-matched healthy controls (HC), with an age range of 6 to 13 years. We evaluated characteristics, nodal properties, and the coupling between SCN and FCN across 90 brain nodes.

View Article and Find Full Text PDF